Treatment with the probiotic VSL#3 as an adjunctive therapy in relapsing mild-to-moderate ulcerative colitis significantly reduces ulcerative colitis disease activity

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Evidence-Based Medicine

• Publication date

  2011-02-24

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/ebm1189PMID 21354984
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Probiotic preparation VSL#3 induces remission in children with mild to moderate acute ulcerative colitis: A pilot study

  2009cited by this paper
• Effect of a Probiotic Preparation (VSL#3) on Induction and Maintenance of Remission in Children With Ulcerative Colitis

  2009influential reference
• The probiotic preparation, VSL#3 induces remission in patients with mild-to-moderately active ulcerative colitis.

  2009cited by this paper
• VSL#3 Probiotic-Mixture Induces Remission in Patients with Active Ulcerative Colitis

  2005cited by this paper
• Low-dose balsalazide plus a high-potency probiotic preparation is more effective than balsalazide alone or mesalazine in the treatment of acute mild-to-moderate ulcerative colitis.

  2004cited by this paper

• Effects of combined OncoTherad immunotherapy and probiotic supplementation on modulating the chronic inflammatory process in colorectal carcinogenesis.

  2022cites this paper
• Limosilactobacillus reuteri DS0384 promotes intestinal epithelial maturation via the postbiotic effect in human intestinal organoids and infant mice

  2022cites this paper
• Protective effects of Lizhong decoction on ulcerative colitis mice by suppressing inflammation and ameliorating gut barrier.

  2020cites this paper
• Probiotics for induction of remission in ulcerative colitis.

  2020influential citation
• Assessing the efficacy and safety of fecal microbiota transplantation and probiotic VSL#3 for active ulcerative colitis: A systematic review and meta-analysis

  2020cites this paper
• Unraveling of ulcerative colitis and its therapy: A review

  2018cites this paper
• The Emerging Therapeutic Role of Medical Foods for Gastrointestinal Disorders.

  2017cites this paper
• Probiotics and the Microbiome in Celiac Disease: A Randomised Controlled Trial

  2016cites this paper
• Investigating the role of intestinal microflora in the aetiology, symptom scores and life quality of people with coeliac disease

  2013cites this paper
• Investigation of the impact of feeding Lactobacillus plantarum CRL 1815 encapsulated in microbially derived polymers on the rat faecal microbiota

  2012cites this paper
• Stability of lactobacilli encapsulated in various microbial polymers.

  2012cites this paper
• Probiotics Applications in Autoimmune Diseases

  2012cites this paper
• Molecular Analysis Reveals Unique Microbiome in Ileal Pouch During Pouchitis Compared to Healthy Pouches in Ulcerative Colitis and Familial Adenomatous Polyposis

  2011cites this paper